DBV Technologies SA (DBVT)
0.4881
-0.02
(-3.92%)
USD |
NASDAQ |
Nov 21, 16:00
0.4801
-0.01
(-1.64%)
After-Hours: 20:00
DBV Technologies Enterprise Value: 1.221M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.221M |
| November 20, 2024 | 3.136M |
| November 19, 2024 | 1.500M |
| November 18, 2024 | 3.328M |
| November 15, 2024 | 11.01M |
| November 14, 2024 | 8.138M |
| November 13, 2024 | 13.91M |
| November 12, 2024 | 15.26M |
| November 11, 2024 | 19.20M |
| November 08, 2024 | 19.20M |
| November 07, 2024 | 25.38M |
| November 06, 2024 | 28.34M |
| November 05, 2024 | 27.43M |
| November 04, 2024 | 29.30M |
| November 01, 2024 | 27.49M |
| October 31, 2024 | 29.15M |
| October 30, 2024 | 31.48M |
| October 29, 2024 | 33.15M |
| October 28, 2024 | 30.46M |
| October 25, 2024 | 37.62M |
| October 24, 2024 | 34.84M |
| October 23, 2024 | 19.69M |
| October 22, 2024 | 21.61M |
| October 21, 2024 | 21.70M |
| October 18, 2024 | 22.10M |
| Date | Value |
|---|---|
| October 17, 2024 | 23.53M |
| October 16, 2024 | 21.61M |
| October 15, 2024 | 19.36M |
| October 14, 2024 | 20.24M |
| October 11, 2024 | 20.99M |
| October 10, 2024 | 22.53M |
| October 09, 2024 | 22.09M |
| October 08, 2024 | 22.10M |
| October 07, 2024 | 19.68M |
| October 04, 2024 | 21.61M |
| October 03, 2024 | 19.68M |
| October 02, 2024 | 17.76M |
| October 01, 2024 | 24.49M |
| September 30, 2024 | 21.61M |
| September 27, 2024 | 1.170M |
| September 26, 2024 | 0.1209M |
| September 25, 2024 | 1.564M |
| September 24, 2024 | 4.451M |
| September 23, 2024 | 1.574M |
| September 20, 2024 | 5.894M |
| September 19, 2024 | 4.451M |
| September 18, 2024 | 2.526M |
| September 17, 2024 | 6.375M |
| September 16, 2024 | 6.375M |
| September 13, 2024 | 4.037M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-100.94M
Minimum
Oct 28 2020
1.030B
Maximum
Jan 10 2020
200.44M
Average
106.37M
Median
Enterprise Value Benchmarks
| Edap TMS SA | 68.17M |
| Cellectis SA | -28.39M |
| Genfit SA | 212.18M |
| Adaptimmune Therapeutics PLC | 26.67M |
| Akari Therapeutics PLC | 24.35M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -30.44M |
| Total Expenses (Quarterly) | 30.33M |
| EPS Diluted (Quarterly) | -0.32 |
| Earnings Yield | -215.1% |